[1]
Helbig, G., Bober, G., Seweryn, M., Wichary, R., Tukiendorf, A., Sedlak, L., Oleksy, T. and Kyrcz-Krzemien, S. 2015. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. Mediterranean Journal of Hematology and Infectious Diseases. 7, 1 (Jan. 2015), e2015003. DOI:https://doi.org/10.4084/mjhid.2015.003.